Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first ...

Higher coffee consumption is causally linked to delayed onset of Parkinson’s disease but does not affect disease risk or ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

A groundbreaking study by researchers at Wuhan University, China, has identified a cholesterol metabolite that plays a ...

Parkinson’s disease may be linked to a cholesterol by-product that helps harmful protein clumps spread in the brain, a ...

AstraZeneca’s diabetes drug Bydureon (exenatide) has failed to slow the progression of Parkinson’s disease motor symptoms in a Phase III trial. The University College London (UCL) in the UK ...